Advertisement
Screener

10x Genomics, Inc. (TXG) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Retained Earnings

10x Genomics, Inc. (TXG) had Retained Earnings of -$1.54 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07

  • 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.54B.
  • 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.52B.
  • 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.51B.
  • 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.49B.
Period endRetained Earnings (Accumulated Deficit)
2026-06-30-$1.54B
10-Q · filed 2026-08-07
2026-03-31-$1.52B
10-Q · filed 2026-05-08
2025-12-31-$1.51B
10-Q · filed 2026-08-07
2025-09-30-$1.49B
10-Q · filed 2025-11-07
2025-06-30-$1.47B
10-Q · filed 2025-08-08
2025-03-31-$1.50B
10-Q · filed 2025-05-09
2024-12-31-$1.47B
10-K · filed 2026-02-13
2024-09-30-$1.42B
10-Q · filed 2024-10-29
2024-06-30-$1.38B
10-Q · filed 2024-08-08
2024-03-31-$1.34B
10-Q · filed 2024-04-30
2023-12-31-$1.28B
10-K · filed 2025-02-13
2023-09-30-$1.24B
10-Q · filed 2023-11-03
2023-06-30-$1.14B
10-Q · filed 2023-08-04
2023-03-31-$1.08B
10-Q · filed 2023-05-04
2022-12-31-$1.03B
10-K · filed 2024-02-15
2022-09-30-$1.01B
10-Q · filed 2022-11-03
2022-06-30-$970.19M
10-Q · filed 2022-08-09
2022-03-31-$905.73M
10-Q · filed 2022-05-05
2021-12-31-$863.32M
10-K · filed 2023-02-16
2021-09-30-$844.87M
10-Q · filed 2021-11-05
2021-06-30-$827.70M
10-Q · filed 2021-08-06
2021-03-31-$816.65M
10-Q · filed 2021-05-07
2020-12-31-$805.10M
10-K · filed 2022-02-18
2020-09-30-$389.52M
10-Q · filed 2020-11-12
2020-06-30-$323.68M
10-Q · filed 2020-08-12
2020-03-31-$283.51M
10-Q · filed 2020-05-12
2019-12-31-$262.37M
10-K · filed 2021-02-26
2019-09-30-$255.23M
10-Q · filed 2019-11-12
2018-12-31-$231.12M
10-K · filed 2020-02-27